Related Experiment Video
Updated: Jun 23, 2026
07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms
1Children's Hospital and Harvard Medical School, Karp Family Laboratories, Boston, MA 02115, USA. michael.retsky@childrens.harvard.edu
Summary
Challenging breast cancer dogma, research suggests tumors can enter dormancy and surgery may awaken dormant cells, accelerating relapse. A new dormancy preservation therapy is proposed.
Area of Science:
- Oncology
- Mathematical Biology
- Cancer Research
Background:
- Traditional breast cancer models assume continuous tumor growth.
- This paradigm is challenged by new evidence suggesting tumor dormancy.
- Primary tumor removal may inadvertently trigger dormant micrometastases.
Purpose of the Study:
- To investigate the role of tumor dormancy in breast cancer progression.
- To analyze the impact of primary tumor surgery on dormant micrometastases.
- To propose a novel therapeutic approach based on dormancy preservation.
Main Methods:
- Utilized a numerical algorithm to model tumor growth dynamics.
- Analyzed data to identify periods of quasi-stable tumor dormancy.
- Correlated primary tumor removal with accelerated relapse rates.
Main Results:
- Breast cancer growth frequently involves extended periods of dormancy.
- Surgical removal of the primary tumor can awaken dormant micrometastases.
- Over 50% of breast cancer relapses may be accelerated by this mechanism.
Conclusions:
- Fundamental concepts of breast cancer growth require revision.
- Tumor dormancy plays a critical role in disease relapse.
- Dormancy preservation therapy offers a potential new treatment strategy.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...